electroCore, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
electroCore, Inc. (ECOR) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $53.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- electroCore, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $27.00K, a 28.95% decline year-over-year.
- electroCore, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $26.00K, a 33.33% decline year-over-year.
- electroCore, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $1.06M, a 157.77% increase year-over-year.
- electroCore, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $35.00K, a 18.60% decline year-over-year.
- electroCore, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.17M, a 135.74% increase from fiscal 2024.
- electroCore, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $498.00K, a 690.48% increase from fiscal 2023.
- electroCore, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $63.00K, a 31.25% increase from fiscal 2022.
- electroCore, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $48.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $53.00K 10-Q · filed 2026-08-06 | $1.11M derived: sum of 3 quarters · filed 2026-08-06 | $1.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $26.00K 10-Q · filed 2026-05-06 | $1.09M derived: sum of 2 quarters · filed 2026-05-06 | $1.12M derived: sum of 3 quarters · filed 2026-05-06 | $1.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.10M derived: sum of 2 quarters · filed 2026-03-19 | $1.14M derived: sum of 3 quarters · filed 2026-08-06 | $1.17M 10-K · filed 2026-03-19 |
| 2025-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $73.00K derived: sum of 2 quarters · filed 2026-08-06 | $112.00K 10-Q · filed 2025-11-05 | $524.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $77.00K 10-Q · filed 2026-08-06 | $489.00K derived: sum of 3 quarters · filed 2026-08-06 | $532.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $39.00K 10-Q · filed 2026-05-06 | $451.00K derived: sum of 2 quarters · filed 2026-05-06 | $494.00K derived: sum of 3 quarters · filed 2026-05-06 | $520.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $455.00K derived: sum of 2 quarters · filed 2026-03-19 | $481.00K derived: sum of 3 quarters · filed 2026-03-19 | $498.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $69.00K derived: sum of 2 quarters · filed 2025-11-05 | $86.00K 10-Q · filed 2025-11-05 | $103.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $43.00K 10-Q · filed 2025-08-06 | $60.00K derived: sum of 3 quarters · filed 2025-08-06 | $76.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $17.00K 10-Q · filed 2025-05-07 | $34.00K derived: sum of 2 quarters · filed 2025-05-07 | $50.00K derived: sum of 3 quarters · filed 2025-05-07 | $65.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $33.00K derived: sum of 2 quarters · filed 2025-03-12 | $48.00K derived: sum of 3 quarters · filed 2025-03-12 | $63.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $31.00K derived: sum of 2 quarters · filed 2024-11-13 | $46.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $30.00K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $15.00K 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $48.00K 10-K · filed 2024-03-13 | |||
| 2020-12-31 | $557.54K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |